REG - Kanabo Group PLC - Notice of AGM

KanaboAnnouncement

31/05/2024 10:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240531:nRSe6544Qa&default-theme=true

RNS Number : 6544Q  Kanabo Group PLC  31 May 2024

31 May 2024

 

Kanabo Group plc

("Kanabo", the "Group" or the "Company")

 

Notice of Annual General Meeting

 

Kanabo Group plc (LSE: KNB), the patient focused healthcare technology and
medicinal cannabis company, announces the Notice of Annual General Meeting
("Notice of Meeting") has now been published. The document has been posted to
shareholders and is now available to download from the Company's
website: https://www.kanabogroup.com/ (https://www.kanabogroup.com/)

 

The Company's Annual General Meeting is scheduled to be held on Thursday, 27
June 2024 at 6th Floor, Saddlers House, 44 Gutter Lane, London, EC2V 6BR.
The meeting will commence at 11.00 a.m.

 

The voting results of all resolutions put before the 2024 AGM will be
announced shortly afterwards.

 

 

Enquiries:

 

 Kanabo Group plc                                        via Peterhouse Capital

 Avihu Tamir, Chief Executive Officer                    +44 (0)20 7469 0930

 Assaf Vardimon, Chief Financial Officer

 Ian Mattioli,  Non-Executive Chair of the Board

 Peterhouse Capital Ltd (Financial Adviser and Broker)   +44 (0)20 7469 0930

 Eran Zucker / Lucy Williams / Charles Goodfellow

 

About Kanabo Group Plc

Kanabo Group plc (LSE:KNB) is a digital health company committed to
transforming patient care through its innovative technology platform and
specialised treatment offerings. Since its inception in 2017, Kanabo has been
focused on researching, developing, and commercialising regulated medicinal
cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides
patients with video consultations, online prescriptions, and primary care
services. Leveraging its telehealth capabilities, in February 2023, Kanabo
launched Treat It, an online clinic focused on chronic pain management that
provides patients with secondary care.

 

With its two complementary business divisions, Kanabo has established itself
as an end-to-end digital health provider. It offers telehealth consultations,
prescriptions and tailor-made treatments.

 

The Company's partially owned subsidiary, Kanabo Agritec Ltd, is a cultivation
consultancy supporting cannabis businesses in developing new farms through
infrastructural, research, and product guidance. These farms deliver
high-quality raw materials for Kanabo's formulas and product line.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest
quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com (http://www.kanabogroup.com/)  for more
information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NOAEANSFDANLEEA